Zusammenfassung
Das Prostatakarzinom ist zum häufigsten malignen Tumor des älteren Mannes geworden. Nur vereinzelt wird es vor dem 50. Lebensjahr beobachtet, danach steigt die Häufigkeit rasch an. In den europäischen Ländern und den USA steht dieser Tumor in der Todesursachenstatistik der Männer an zweiter Stelle nach den Lungentumoren. Jährlich sterben daran in Deutschland etwa 12 000 Männer. In den USA hat die Inzidenz zwischen 1970 und 1985 (56 und 75 Neuerkrankungen pro 100 000 weiße Einwohner) beträchtlich zugenommen; dies wird auf die verbesserte Früherkennung zurückgeführt (Devesa et al. 1987). In Deutschland ist die Inzidenz zwischen 1975 und 1988 gleich geblieben, im Rahmen der gesetzlichen Früherkennung wurden 85 Karzinome bei 100 000 Untersuchten entdeckt (Flatten 1991). Diese Zahl ist jedoch nicht mit der Inzidenz gleichzusetzen, die mit 66/100 000 angenommen wird. Die Inzidenz ist bei schwarzen Männern in den USA mit 95 pro 100 000 deutlich höher als bei der weißen Bevölkerung, besonders niedrig ist sie in Japan und China (Doll 1978). Wenn Japaner in die USA einwandern, nimmt auch bei ihnen die Inzidenzrate langsam zu (Haenszel u. Kurihara 1968).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Ackermann R, Altwein JE, Faul P (Hrsg) (1991) Aktuelle Therapie des Prostatakarzinoms. Springer, Berlin Heidelberg New York Tokyo
Altwein JE, Paul P (1991) Probleme und Prinzipien der Hormontherapie des fortgeschrittenen Prostatakarzinoms. In: Ackermann R, Altwein JE, Faul P (Hrsg) Aktuelle Therapie des Prostatakarzinoms. Springer, Berlin Heidelberg New York Tokyo, S 230–2249
Asbell SO, Schlager BA, Baker AS (1980) Revision of treatment planning for carcinoma of the prostate. Int J Radiat Oncol Biol Phys 6: 681–685
Asbell SO, Krall JM, Pilepich MV et al. (1988) Elective pelvic irradiation in stage A2, B carcinoma of the prostate: a analysis of RTOG 77–06. Int J Radiat Oncol Biol Phys 15: 1307–1316
Bagshaw MA (1984) A technique for external beam irradiation of carcinoma of the prostate. In: Levitt SH, du Tapley NV (eds) Technological basis of radiation therapy. Lea & Febiger, Philadelphia, pp 244–270
Bagshaw MA (1985) Potential for radiotherapy alone in pro-static cancer. Cancer 55: 2079–2085
Bagshaw MA, Kaplan HS, Sagerman RH (1965) Linear accelerator supervoltage radiotherapy. VII. Carcinoma of the prostate. Radiology 85: 121
Batterman JJ, Boon TA, van Es C et al. (1989) Brachytherapy in the management of prostate cancer. In: Brachytherapy 2, Proc 5th Int Selection Users Meeting 1988. Nucletron, Leersum, pp 159–164
Belt E, Schroeder FH (1972) Total perineal prostatectomy for carcinoma of the prostate. J Urol 107: 91–96
Budach V (1991) The role of fast neutrons in radiooncology–a critical appraisal. Strahlenther Onkol 107: 110–14
Byar DP, Mostofi FK (1972) Carcinoma of the prostate: prognostic evaluation of certain pathological features in 208 radical prostatectomies–examined by the step section technique. Cancer 3o: 5–13
Castellino RA (1988) Lymphography in clinically localized prostate cancer. NCI Monogr 7: 37
Chodak GW, Wald V, Parmer E et al. (1986) Comparison of digital examination and transrectal ultrasonography for the diagnosis of prostate cancer. J Urol 135: 951–954
DeLaney TF, Shipley WU, O’Leary MP et al. (1986) Preoperative irradiation, lymphadenectomy, and 125-I implantation for patients with localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys 12: 1779–1785
Del Regato JA (1967) Radiotherapy in the conservative treatment of operable and locally inoperable carcinoma of the prostate. Radiology 88: 761
Devesa SS, Silverman DT, Young JL Jr et al. (1987) Cancer incidence and mortality trends among in the United States, 1947–1984. J Nat Cancer Inst 79: 701
Dewit L, Ang KK, van der Schueren E (1983) Acute side effects and late complications after radiotherapy of localized carcinoma of the prostate. Cancer Treat Rev 10: 79
Dhom G (1991) Epidemiologische und morphogenetische Aspekte des Prostatakarzinoms. Urologe A 30: 3
Doll R (1978) Geographic variation in cancer incidence: a clue to causation. World J Surg 2: 595–602
Elder JS, Jewett MJ, Walsh PC (1982) Radical perineal prostatectomy for clinical stage B2 carcinoma of the prostate. J Urol 127: 704–706
Elder JS, Gibbons RP, Correa RJ Jr et al. (1985) Efficacy of radical prostatectomy for stage A2 carcinoma of the prostate. Cancer 56: 2151–2154
Epstein BE, Hanks GE (1993) Radiation therapy techniques and dose selection in the treatment of prostate cancer. Semin Radiat Oncol 3: 179–186
Fair WR, Perez CA, Anderson T (1993) Cancer of the urethra and penis. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer, 4th edn. Lippincott, Philadelphia
Faul P, Partecke G (1991) Problematik des inzidenten Prostatakarzinoms. In: Ackermann R, Altwein JE, Faul P (Hrsg) Aktuelle Therapie des Prostatakarzinoms. Springer, Berlin Heidelberg New York Tokyo, S 176–192
Flatten G (1991) Gesundheitsökonomische Überlegungen zu den Krebsfrüherkennungsuntersuchungen unter besonderer Berücksichtigung des Prostatakarzinoms. In: Ackermann R, Altwein JE, Paul P (Hrsg) Aktuelle Therapie des Prostatakarzinoms. Springer, Berlin Heidelberg New York Tokyo, S 3–7
Franke HD, Schmidt R (1985) Clinical results with fast neutrons (DT, 14 MeV). Radiat Med 3: 151–160
Freiha FS (1988) Selection criteria for radical prostatectomy based on morphometric studies. NIH Consensus Development Conference: Management of clinically localized prostate cancer. NCI Monogr 7: 136–138
Gibbons RP, Cole BS, Richardson RG et al. (1986) Adjuvant radiotherapy following radical prostatectomy: results and complications. J Urol 135: 65–68
Golimbu M, Schinella R, Morales P, Kurusu S (1978) Differences in pathological characteristics and prognosis of clinical A2 prostatic cancer from Al and B disease. J Urol 119: 618–622
Grossman HB, Batata M, Hilaris B et al. (1982) 125-I implantation for carcinoma of the prostate: further follow-up of first too cases. Urology 20: 591–598
Guinan P, Bush I, Ray V et al. (1980) The accuracy of the rectal examination in the diagnosis of prostate carcinoma. N Engl J Med 303: 499–503
Haenszel W, Kurihara M (1968) Studies of Japanese migrants: I. Mortality from cancer and other disease among Japanese in the United States. J Nat Cancer Inst 40: 43–68
Hammerer P, Huland H (1991) Zur Diagnostik des lokalisierten Prostatakarzinoms: Screening und präoperatives Staging. Urologe A 30: 378–386
Hanks GE (1989) The prostate. In: Moss WT, Cox JD (eds) Radiation oncology, 6th edn. Mosby, St Louis, pp 487–511
Hanks GE, Leibel SA, Krall JM, Kramer S (1985) Patterns of care studies: Dose response of observations for local control of adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 11: 153–157
Hartung R (1991) Nicht-invasive Beckenlymphknotendiagnostik und Staging Lymphadenektomie. In: Ackermann R, Altwein JE, Faul P (Hrsg) Aktuelle Therapie des Prostatakarzinoms. Springer, Berlin Heidelberg New York Tokyo, S 81–91
Helpap B (1989) Pathologie der ableitenden Harnwege und der Prostata. Springer, Berlin Heidelberg New York Tokyo
Hricak H, Jeffrey RB, Dooms GC, Tanagho ES (1987) Evaluation of prostate size: a comparison of ultrasound and magnetic resonance imaging. Urol Radiol 9: 1
Hricak H (1988) Noninvasive imaging for staging of prostate cancer: magnetic resonance imaging, computed tomography, and ultrasound. NCI Monogr 7: 31
Huggins C, Hodges CV (1941) Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1: 293
Jewett HJ (1980) Radical perineal prostatectomy for palpable, clinically localized, nonobstructive cancer: Experience at the John Hopkins Hospital 1909–1963. J Urol 124: 492–494
Kaplan I, Kapp DS, Bagshaw MA (1991) Secondary external beam radiotherapy and hyperthermia for local recurrence after 125-iodine implantation in adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 20: 551–554
Keisch ME, Perez CA, Grigsby CW et al. (1989) Preliminary report on 10 patients treated with radiotherapy after radical prostatectomy for isolated elevation of serum PSA levels. Int J Radiat Oncol Biol Phys 19: 1503–1506
Krieger JN, Krall JM, Laramore GE et al. (1989) Fast neutron radiotherapy for locally advanced prostate cancer. Update of a past trial and future research directions. Urology 34: 1–9
Lang PH (1988) Adjuvant postoperative radiation therapy following radical prostatectomy. Consensus Development Conference: Management of clinically localized prostate cancer. NCI Monogr 7: 122–125
Lawton CA, Won M, Pilepich MV et al. (1991) Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: Analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys 21: 935–939
Link P, Freiha FS, Stamey TA (1991) Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy. J Urol 145: 532–534
Maruoka M, Ando K, Nozumi K et al. (1983) Fast neutron therapy of prostatic cancer. Nippon Hinyokika Gakkai Zasshi 74: 409–417
McGowan DG (1980) The adverse influence of prior transurethral resection on prognosis in carcinoma of the prostate. J Faculty Radiol 6: 1121
McGowan DG (1988) The effect of transurethral resection on prognosis in carcinoma of the prostate: real or imaginary? Int J Radiat Oncol Biol Phys 15: 1057
Middleton RG (1988) Value and indications for pelvic lymph node dissection in the staging of prostate cancer. Nat Cancer Int Monogr 7: 41
Modig H, Tomic R, Granfors T, Nyberg G (1993) Prospective randomized trial in localized prostatic cancer. Radiotherapy versus radiotherapy and orchidectomy. Abstract 1323. ECCO 7 conference Jerusalem. Pergamon, Oxford
Morgan WR, Zincke H, Rainwater LM et al. (1991) Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: Impact of adjuvant treatment (hormonal and radiation). J Urol 145: 319–323
Mostofi FK (1975) Grading of prostatic carcinoma. Cancer Chemother Rev 59: 111–117
Murphy WM, Dean PJ, Brasfield JA, Tatum L (1986) Incidental carcinoma of the prostate. How much sampling is adequate? Am J Pathol 10: 170–174
Myers RP, Fleming TR (1983) Course of localized adenocarcinoma of the prostate treated by radical prostatectomy. Prostate 4: 461–472
Perez CA, Pilepich MV (1992) Penis and male urethra. In: Perez CA, Brady LW (eds) Radiation oncology. 2nd edn. Lippincott, Philadelphia, pp 1131–1142
Perez CA, Fair WR, Ihde DC (1989a) Carcinoma of the prostate. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer–Principles and practice of oncology, 3rd edn. Lippincott, Philadelphia, pp 1023–1058
Perez CA, Garcia D, Simpson JR et al. (1989b) Factors influencing outcome of definitive radiotherapy for localized carcinoma of the prostate. Radiother Oncol 16: 1
Perez CA, Lee HK, Georgiou A et al. (1993) Technical and tumor-related factors affecting outcome of definitive irradiation for localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys 26: 581–591
Perez CA, Georgiou A, Lockett MA (im Druck) Impact of technical factors on outcome of irradiation of carcinoma of the prostate
Peschel RE, Fogel T, Kacinski B et al. (1985) Iodine-125 implants for carcinoma of the prostate. Int J Radiat Oncol Biol Phys 11: 1777–1782
Pilepich MV, Perez CA, Walz BJ, Zivnuska FR (1981) Complications of definitive radiotherapy for carcinoma of the prostate. Int J Radiat Oncol Biol Phys 7: 1341
Pilepich MV, Walz BJ, Baglan RJ (1984a) Postoperative irradiation in carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1o: 1869–1873
Pilepich MV, Krall J, George FW et al. (1984b) Treatment-related morbidity in phase III RTOG studies of extended-field irradiation for carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1o: 1861
Pilepich MV, Krall JM, Johnson RJ et al. (1986) Extended field (periaortic) irradiation in carcinoma of the prostate: Analysis of RTOG 75–95. Int J Radiat Oncol Biol Phys 12: 345
Pilepich MV, Krall JM, Sause WT et al. (1987) Prognostic factors in carcinoma of the prostate: Analysis of RTOG study 75–06. Int J Radiat Oncol Biol Phys 13: 339–349
Pistenma DA, Bagshaw MA, Feiha FS (1979) Extended field radiation therapy for prostatic adenocarcinoma: status report of a limited prospective trial. In: Johnson DE, Samuels ML (eds) Cancer of the genitourinary tract. Raven, New York, pp 229–247
Ray GR, Bagshaw MA, Freiha F (1984) External beam radiation salvage for residual or recurrent local tumor following radical prostatectomy. J Urol 132: 926–930
Richard F, Renard L, Wambersie A (1986) Current results of neutron therapy at the UCL for soft tissue sarcomas and prostatic adenocarcinomas. Bull Cancer 73: 562–568
Rifkin MD, Zerhoni EA, Gatsornis EA (1990) Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. N Engl J Med 323: 621–626
Robson MC (1966) Cirrhosis and prostatic neoplasm. Geriatrics 21: 150–154
Rosenthal SA, Roach III M, Goldsmith BJ et al. (1993) Immobilization improves the reproducibility of patient positioning during six-field conformal radiation therapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 27: 921–926
Rübben H (1991) Chemotherapie des Prostatakarzinoms. In: Ackermann R, Altwein JE, Faul P (Hrsg) Aktuelle Therapie des Prostatakarzinoms. Springer, Berlin Heidelberg New York Tokyo, S 321–338
Rübben H (1993) Penis. In: Dold U, Hermanek P, Höffken K, Sack H (Hrsg) Praktische Tumortherapie. Thieme, Stuttgart, S 547–551
Rübben H (Hrsg) (1994) Uroonkologie. Springer, Berlin Heidelberg New York Tokyo
Russell KJ, Laramore GE, Krall FJ et al. (1987) Eight years experience with neutron radiotherapy in the treatment of stages C and D prostate cancer: updated results of the RTOG 7704 randomized clinical trial. Prostate 11: 183–193
Sack H, Nosbüsch H, Stützer H (1987) Radiotherapy of prostate carcinoma: results of treatment and complications. Radiother Oncol 19: 7–15
Sagerman RH, Fireman MJ (1993) The dilemma of positive prostatectomy margins. Abstract 1321. ECCO 7 conference Jerusalem. Pergamon, Oxford
Servadio C, Leib Z (1984) Hyperthermia in the treatment of prostate cancer. Prostate 5: 205–211
Ten Haken RK, Perez-Tamayo C, Tesser RJ et al. (1989) Boost treatment of the prostate using shaped fixed fields. Int J Radiat Oncol Biol Phys 16: 193–200
Ten Haken RK, Forman JD, Heimburger DK et al. (1991) Treatment planning issues related to prostate movement in response to differential filling of the rectum and bladder. Int J Radiat Oncol Biol Phys 20: 1317–1324
UICC (1992) TNM-Klassifikation maligner Tumoren, 4. Aufl, 2. Rev. Springer, Berlin Heidelberg New York Tokyo
Viola MV, Fronowitz F, Oravez S et al. (1986) Expression of ras oncogene pi in prostate cancer. N Engl J Med 314: 133–137
Walsh PC (1988) Radical retropubic prostatectomy with reduced morbidity: an anatomic approach. NCI Monogr 7: 133–144
Wannenmacher M, Sommerkamp H, Knüfermann H, Hempel M (1988) Interstitielle Strahlentherapie des Prostatakarzinoms mit Jod-125. In: Hammer J, Kärcher KH (Hrsg) Fortschritte in der interstitiellen und intrakavitären Strahlentherapie. Zuckschwerdt, München, S 149–155
Whitmore WF Jr, Batata MA, Hilaris BS (1979) Prostate irradiation. In: Johnson DE, Samuels ML (eds) Cancer of the genitourinary tract. Raven, New York
Wirth M, Frohmüller H (1991) Radikale Prostatektomie mit Erhalt der erektilen Funktion. In: Ackermann R, Altwein JE, Faul P (Hrsg) Aktuelle Therapie des Prostatakarzinoms. Springer, Berlin Heidelberg New York Tokyo, S 131–138
Yerushalmi A (1988) Localized, non-invasive deep microwave hyperthermia for the treatment of prostatic tumors: the first 5 years. In: Issels RD, Wilmanns W (eds) Application of hyperthermia in the treatment of cancer. Springer, Berlin Heidelberg New York Tokyo, S 141–146
Zagars GK (1993) The prognostic significance of a single serum prostate-specific antigen value beyond six months after radiation therapy for adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 27: 39–45
Zagars GK, Eschenbach AC von (1993) Prostate-specific antigen. An important marker for prostate cancer treated by external beam radiation therapy. Cancer 72: 538–548
Zagars GK, Sherman NE, Babaian RJ (1991) Prostate specific antigen and external beam radiation therapy in prostate cancer. Cancer 67: 412–420
Zagars GK, Eschenbach AC von, Ayala AG (1993) Prognostic factors in prostate cancer. Cancer 72: 1709–1725
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Sack, H. (1996). Prostata, Urethra, Penis. In: Scherer, E., Sack, H. (eds) Strahlentherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79432-2_27
Download citation
DOI: https://doi.org/10.1007/978-3-642-79432-2_27
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79433-9
Online ISBN: 978-3-642-79432-2
eBook Packages: Springer Book Archive